Tag: diabetes

Study compares renoprotective effects of metabolic bariatric surgery, GLP-1RA

Editor's Note For diabetic patients with obesity and chronic kidney disease (CKD), metabolic bariatric surgery could protect the kidneys better than therapy with glucagon-like peptide-1 receptor agonists (GLP-1RA), according to research published in the September issue of the Annals of Surgery. Conducted at a large US health system, the study…

Read More

By: Matt Danford
August 13, 2024
Share

Study: Spinal fusion failure more likely for diabetic patients

Editor's Note Lumbar spinal fusion procedures are significantly more likely to fail in individuals with diabetes, according researchers at The University of Toledo. According to a July 9 EurekAlert! report on the study, published in JBMR Plus, diabetic patients are already known to have a higher risk of infection from…

Read More

By: Matt Danford
August 6, 2024
Share

Study: Intraoperative DEX infusions effectively manage diabetes in cardiac surgery patients

Editor's Note Intraoperative infusion of dexmedetomidine (DEX) could help improve glycemic control and reduce insulin requirements in diabetic patients undergoing cardiac surgery, according to a July 25 article in Medical Dialogues. The article focuses on a prospective observational study published in the journal Annals of Cardiac Anesthesia. The study included…

Read More

By: Matt Danford
July 29, 2024
Share

Study results evidence long-term effectiveness of gastric bypass surgery

Editor's Note Roux-en-Y gastric bypass surgery kept type 2 diabetes in remission for up to 15 years and maintained most of the weight loss for up to 20 years in a long-term study, according to a June 12 report in SciTech Daily. Presented the same day at The American Society…

Read More

By: Matt Danford
June 20, 2024
Share

Study: Bariatric surgery outperforms GLP-1 treatment, lifestyle modifications

Editor's Note Bariatric surgery provides longer-lasting, more effective weight loss than GLP-1 receptor agonists and lifestyle interventions, according to systematic reviews of medical literature from 2020 to 2024. Medical Xpress reported the news June 11. Presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting,…

Read More

By: Matt Danford
June 18, 2024
Share

Study: Robot surgery outcomes superior to laparoscopic metabolic, bariatric procedures

Editor's Note Two new studies show robotic surgery outperforming laparoscopic approaches to metabolic and bariatric procedures in terms of operating times, length of hospital stay, and complication rates, according to a June 11 report in Medical Xpress. Both studies were presented at the American Society for Metabolic and Bariatric Surgery…

Read More

By: Matt Danford
June 14, 2024
Share

Study: standard preoperative fasting guidelines safe for GLP-1 patients

Editor's Note Preoperative use of GLP-1 receptor agonists (RA) medications such as Ozempic and Wegovy is safe, according to a study published in the June issue of the American Journal of Gastroenterology. Controversy has swirled around these drugs due to the risk of slowed stomach emptying increasing a patient’s odds…

Read More

By: Matt Danford
June 7, 2024
Share

Type 2 diabetes case cured via stem cell therapy, researchers report

Editor's Note Researchers claim a stem cell transplant cured type 2 diabetes in a 59-year-old man who previously needed multiple daily insulin injections, the South China Morning Post reported May 27. The Chinese researchers behind the reported breakthrough published details of the case April 30 in the journal Cell Discovery.…

Read More

By: Matt Danford
May 31, 2024
Share

Study: Infection risk unaffected by colonoscopy, joint replacement timing

JAMA (healthcare publication) Network logo

Editor's Note A study published May 7 in JAMA Open found no significant risk of periprosthetic joint infection (PJI) when colonoscopy is performed within one year of total joint arthroplasty (TJA), whether the colonoscopy was done before or after the surgery. However, certain comorbidities such as kidney and pulmonary disease,…

Read More

By: Matt Danford
May 28, 2024
Share

Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients

Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…

Read More

By: Matt Danford
May 28, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat